NCT01722903
Detection of CTCs in Patients Undergoing Surgery for Stage IV Colorectal Cancer No drug interventions Not Available Not Available completed NCT01704703
Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques treatment 2 completed NCT03800602
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer treatment 2 completed NCT04670445
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT01074385
Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making No drug interventions supportive_care Not Available completed NCT04267575
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites No drug interventions treatment Not Available unknown_status NCT03368963
TAS102 in Combination With NAL-IRI in Advanced GI Cancers treatment 1 / 2 recruiting NCT03275974
Glutamine PET Imaging Colorectal Cancer diagnostic 1 active_not_recruiting NCT01271582
Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients treatment 4 unknown_status NCT02960282
Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or Immunotherapy No drug interventions Not Available Not Available terminated NCT01550510
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA treatment 1 / 2 terminated NCT03095781
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer treatment 1 completed NCT06287723
French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM) Not Available Not Available not_yet_recruiting NCT03111823
Exercise Program During Chemotherapy in Metastatic Colorectal Cancer No drug interventions supportive_care Not Available terminated NCT03005002
Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver treatment 1 completed NCT03373188
VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer treatment 1 completed NCT01998152
Individualized Nutritional Counselling During Chemotherapy for Colorectal Cancer (COLONUT) No drug interventions treatment Not Available completed NCT02809716
High Definition Single Cell Analysis in Colorectal Cancer No drug interventions Not Available Not Available completed NCT04044430
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer treatment 1 terminated NCT05025748
Ask Questions (ASQ):Implementation of a Communication Intervention No drug interventions health_services_research Not Available completed NCT05631574
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer No drug interventions treatment 1 recruiting NCT03087591
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery No drug interventions treatment 1 completed NCT02919644
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer. No drug interventions treatment 2 unknown_status NCT03112668
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners No drug interventions supportive_care Not Available completed NCT00784446
First-line Therapy of Stage IV Colorectal Cancer treatment 1 / 2 completed NCT04715061
Impact of Aerobic Exercise on Immune Response and Side Effects of Cancer Treatments No drug interventions supportive_care Not Available completed NCT06296056
Phase I Study of Combined Immune Cell Therapy in Patients With Stage 4 Colorectal Cancer With Metastatic Lesion Who Failed Prior Standard of Care No drug interventions treatment 1 not_yet_recruiting NCT01570452
Matrilysin Expression in Different Stages of Colorectal Tumors No drug interventions Not Available Not Available completed NCT05164419
Impact de la Marge de résection Sur la Survie à Long Terme et le Taux de récidive Des Patients Atteints de Cancers Colorectaux opérés au CHUS Entre 2006 et 2016 Pour Des métastases hépatiques No drug interventions Not Available Not Available completed NCT05451719
Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy treatment 2 not_yet_recruiting NCT05354817
Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin No drug interventions treatment 2 unknown_status NCT05576896
Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory treatment 2 recruiting NCT04157322
Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis No drug interventions Not Available Not Available active_not_recruiting NCT03594448
Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients No drug interventions Not Available Not Available terminated NCT04917276
Treatment Response Prediction System of mCRC Patients Based on CTC No drug interventions Not Available Not Available not_yet_recruiting NCT06342440
Early Detection of Advanced Adenomas and Colorectal Cancer No drug interventions Not Available Not Available recruiting NCT05550701
Prognostic Impact of Increased Lymph Node Yield in Colorectal Cancer Patients With Synchronous Distant Metastasis: a Population-based Study of the US Database and a Chinese Registry No drug interventions Not Available Not Available completed NCT03542214
Calcium Electroporation for the Treatment of Colorectal Cancer device_feasibility 1 completed NCT03149679
The p53 Colorectal Cancer Trial treatment 2 terminated NCT05426005
Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer treatment 1 / 2 recruiting NCT06329700
Parenchymal Sparing Hepatectomy in Post-chemotherapy Liver Atrophy No drug interventions Not Available Not Available completed NCT04149613
Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer No drug interventions Not Available Not Available enrolling_by_invitation NCT05382741
Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial treatment 2 recruiting NCT03986541
AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer No drug interventions Not Available Not Available completed NCT04425239
Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer treatment 2 completed NCT06509126
Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer treatment 3 recruiting NCT05289726
Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105 No drug interventions prevention 2 unknown_status NCT05171660
Combination With Sintilimab and XELOX+Bevacizumab as 1st Line Therapy in RAS-mutant Metastatic Colorectal Cancer treatment 3 recruiting NCT03031444
Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis treatment 2 / 3 completed NCT06342401
Early Onset Colorectal Cancer Detection No drug interventions Not Available Not Available recruiting NCT04714814
Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis No drug interventions Not Available Not Available unknown_status NCT02618850
PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment No drug interventions treatment Not Available active_not_recruiting NCT06147037
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients with Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT06349642
Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform No drug interventions Not Available Not Available recruiting NCT05322590
BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma treatment 1 / 2 recruiting NCT04616183
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer treatment 1 / 2 active_not_recruiting NCT04221893
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers No drug interventions treatment Not Available recruiting NCT06269978
Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer treatment 1 recruiting NCT03290937
Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer treatment 1 active_not_recruiting NCT02298959
Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer treatment 1 active_not_recruiting NCT03096899
A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma No drug interventions Not Available Not Available withdrawn NCT02738606
Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery No drug interventions treatment 2 active_not_recruiting NCT06115174
Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer other 4 not_yet_recruiting NCT03993327
An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer diagnostic 1 completed NCT05130060
A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer treatment 1 completed NCT04329494
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer treatment 1 recruiting NCT02757391
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors treatment 1 terminated NCT04599140
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial treatment 1 / 2 recruiting NCT04535401
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines treatment 1 active_not_recruiting NCT02873195
Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer treatment 2 completed NCT03981614
Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer treatment 2 completed NCT04673955
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment Not Available Not Available recruiting NCT02888743
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT04294264
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer treatment 2 active_not_recruiting NCT03337087
Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer treatment 1 / 2 active_not_recruiting NCT04693377
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial No drug interventions supportive_care Not Available recruiting NCT03992456
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer treatment 2 active_not_recruiting NCT06265285
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program health_services_research 2 recruiting NCT01937715
A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer treatment 1 / 2 terminated NCT06449937
Local Liver Treatment for Multi-organ Colorectal Cancer Metastases No drug interventions treatment Not Available recruiting NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors treatment 2 recruiting NCT04796818
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response No drug interventions diagnostic Not Available active_not_recruiting NCT03317119
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery treatment 1 completed NCT04096417
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations treatment 2 active_not_recruiting NCT05061017
Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC) treatment 2 completed NCT04362839
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer treatment 1 active_not_recruiting NCT04430725
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study No drug interventions Not Available Not Available recruiting NCT05803382
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers treatment 1 recruiting NCT02595931
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery treatment 1 active_not_recruiting NCT03823144
Intravital Microscopy in Human Solid Tumors diagnostic Not Available completed NCT04164069
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab prevention 1 active_not_recruiting NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial treatment 3 recruiting NCT04761614
Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer treatment 1 active_not_recruiting NCT05759923
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours No drug interventions treatment 1 recruiting